B2RLaw has advised biochemical monitoring start-up IQ Biozoom on its investment round led by the VC Link fund.
IQ Biozoom is a Polish start-up developing technology for non-invasive monitoring of levels of biochemical substances in the body, such as glucose, cholesterol, and other biomarkers.
According to B2RLaw, “the company is currently working on developing a device at the heart of which is a biosensor, manufactured using so-called jet printing, based on a proprietary design of advanced semiconductor devices, such as thin-film transistors, among others. The technology is not yet in commercial use. The company has just received investment support from the VC Link fund.”
The VC Link fund’s portfolio mainly includes entities developing technologies for the industrial, high-tech, and IT sectors.
The B2RLaw team included Partner Agnieszka Hajos-Iwanska and Junior Associate Magdalena Borychowska.
B2RLaw could not provide additional information on the deal.